Cubist Systematic Strategies, LLC - POINT BIOPHARMA GLOBAL INC ownership

POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 35 filers reported holding POINT BIOPHARMA GLOBAL INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of POINT BIOPHARMA GLOBAL INC
ValueSharesWeighting
Q2 2023$1,224,192
+793.6%
135,120
+617.0%
0.01%
+700.0%
Q1 2023$137,001
-65.0%
18,845
-64.9%
0.00%
-50.0%
Q4 2022$391,517
-42.5%
53,706
-39.0%
0.00%
-50.0%
Q3 2022$681,000
+6090.9%
88,084
+5405.2%
0.00%
Q2 2022$11,000
-95.9%
1,600
-95.3%
0.00%
-100.0%
Q1 2022$270,000
+864.3%
33,896
+832.0%
0.00%
Q3 2021$28,0003,6370.00%
Other shareholders
POINT BIOPHARMA GLOBAL INC shareholders Q3 2021
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 2,312,523$18,431,0004.36%
GREAT POINT PARTNERS LLC 2,060,000$16,418,0003.97%
RA Capital Management 9,003,018$71,754,0001.57%
JOHNSON & JOHNSON 1,000,000$7,970,0001.51%
BVF INC/IL 3,367,826$26,842,0001.07%
Boxer Capital, LLC 2,500,000$19,925,0001.02%
Sio Capital Management, LLC 377,684$3,010,0001.00%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,014,408$24,025,0000.73%
SILVERARC CAPITAL MANAGEMENT, LLC 204,679$1,631,0000.68%
Atom Investors LP 60,103$479,0000.22%
View complete list of POINT BIOPHARMA GLOBAL INC shareholders